Low-Dose Treatment with Erythropoiesis-Stimulating Agents and Cardiovascular Geometry in Chronic Kidney Disease: Is Darbepoetin-α More Effective than Expected?

MLA

Di Lullo, Luca, et al. “Low-Dose Treatment with Erythropoiesis-Stimulating Agents and Cardiovascular Geometry in Chronic Kidney Disease: Is Darbepoetin-α More Effective than Expected?” Cardiorenal Medicine, vol. 2, no. 1, Feb. 2012, pp. 18–25. EBSCOhost, https://doi.org/10.1159/000334942.

APA

Di Lullo, L., Floccari, F., Granata, A., & Malaguti, M. (2012). Low-Dose Treatment with Erythropoiesis-Stimulating Agents and Cardiovascular Geometry in Chronic Kidney Disease: Is Darbepoetin-α More Effective than Expected? Cardiorenal Medicine, 2(1), 18–25. https://doi.org/10.1159/000334942

Chicago

Di Lullo, Luca, Fulvio Floccari, Antonio Granata, and Moreno Malaguti. 2012. “Low-Dose Treatment with Erythropoiesis-Stimulating Agents and Cardiovascular Geometry in Chronic Kidney Disease: Is Darbepoetin-α More Effective than Expected?” Cardiorenal Medicine 2 (1): 18–25. doi:10.1159/000334942.